- Title
-
Shoring up the pharma supply chain in 2021 and beyond
- Section
- Insight
- Summary
![](https://eff10-live-8c0e29e302634ae9935a723815c2-b8c89ce.divio-media.org/filer_public_thumbnails/filer_public/d5/9e/d59ed492-6b7e-410b-99d3-61d4c8eef487/pharma__healthcare_1.jpg__1320x880_q85_crop_subsampling-2_upscale.jpg)
The pharmaceutical supply chain has faced undeniable pressure as a result of the ongoing pandemic – which has, in turn, exposed a number of weak links.
Melaye Ras-Work, Co-founder and Vice President at Efficio, reveals the weak links, as well as four key steps pharma companies should take now to build a more robust procurement function that tackles these challenges, in a new article for Manufacturing Chemist.
Read the full article